Search Search by keyword Filter Diseases & Conditions — ADHDAlzheimer’s DiseaseAmyloidosisAnemia in Chronic Kidney DiseaseAsthmaAtopic DermatitisBehavioral HealthBeta ThalassemiaCancerCardiovascular DiseaseChronic PainCommunity HealthCOVID-19Cystic FibrosisDiabetesDuchenne Muscular DystrophyEndometriosisHemophilia AHepatitis CHereditary AngioedemaHypertrophic CardiomyopathyLupus NephritisMethods Update: Ultra-Rare DiseaseMethods Update: Value Assessment FrameworkMethods Update: Valuing A CureMigraineMultiple SclerosisMyasthenia GravisNASHObesity ManagementOpioid EpidemicOsteoporosisPalliative CarePeanut AllergyPolicy: Fair AccessPolicy: Gene TherapiesPolicy: Indication Specific PricingPolicy: Real World EvidencePolicy: RebatesPolicy: Unsupported Price IncreasePsoriasisPTSD: Service DogsRetinal DiseaseRheumatoid ArthritisSickle Cell DiseaseSleep ApneaSpinal Muscular AtrophyTardive DyskinesiaUlcerative Colitis Status — Ongoing Completed Year Completed — 200720082009201020112012201320142015201620172018201920202021 Research Type — AssessmentPolicy Paper Results: Ongoing & Completed Policy Papers Unsupported Price Increases Occurring in 2019 Jan 2021 Cornerstones of ‘Fair’ Drug Coverage Sep 2020 Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19 Jul 2020 Methods Update: Value Assessment Framework Jan 2020 Unsupported Price Increases Occurring in 2017-2018 Oct 2019 Methods Update: Valuing a Cure Sep 2019 Alternative Models for Pharmaceutical Rebates Dec 2018 A Framework to Guide the Optimal Development and Use of Real World Evidence for Coverage and Formulary Decisions Dec 2017 Methods Update: Treatments for Ultra-Rare Diseases May 2017 Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value Dec 2016 Indication-specific pricing: pharmaceuticals in the United States health care system Dec 2015 Alzheimer’s Disease: Evaluating Diagnostics Dec 2012
